{"transactions":[{"id":3630863,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":159826,"kind":"person","name":"Ward Ana","position":1,"cik":"0001716354","reported_name":"Ward Ana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-02-27T02:44:29.000Z","date":"2019-02-24","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on February 24, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date."}],"balance_after":40000,"derivative":{"exercise_price":1.89,"expiration_date":"2029-02-23","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-19-013907","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919119013907/doc4.xml","form_type":"4"}},{"id":3830187,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":159826,"kind":"person","name":"Ward Ana","position":1,"cik":"0001716354","reported_name":"Ward Ana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-08-29T22:28:28.000Z","date":"2018-08-27","kind":"grant","acquired":true,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option, representing a right to purchase a total of 11,250 shares becomes exercisable in two equal annual installments beginning on August 27, 2019, subject to the Reporting Person's continued service through each such date."}],"balance_after":11250,"derivative":{"exercise_price":6.4,"expiration_date":"2028-08-27","underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001209191-18-048861","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919118048861/doc4.xml","form_type":"4"}},{"id":4092125,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":159826,"kind":"person","name":"Ward Ana","position":1,"cik":"0001716354","reported_name":"Ward Ana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-01-23T21:45:07.000Z","date":"2018-01-19","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on January 19, 2019 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued service through each such date."}],"balance_after":20000,"derivative":{"exercise_price":9.18,"expiration_date":"2028-01-18","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-18-004913","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919118004913/doc4.xml","form_type":"4"}},{"id":4215571,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":159826,"kind":"person","name":"Ward Ana","position":1,"cik":"0001716354","reported_name":"Ward Ana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option Grant (Right to Buy)","published_at":"2017-09-06T22:23:19.000Z","date":"2017-09-05","kind":"grant","acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on September 1, 2018 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued service through each such date."}],"balance_after":95000,"derivative":{"exercise_price":8.38,"expiration_date":"2027-09-04","underlying":"Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0001209191-17-051748","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919117051748/doc4.xml","form_type":"4"}}]}